-
Company Profile
![]()
Ion Beam Applications SA – Company Profile
Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer and other serious illnesses. The company offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The medical technology company focuses its activities on proton therapy solutions, dosimetry, and other accelerators. Its products and services find application in the treatment of cancer, and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company...
Add to Basket -
Company Profile
![]()
DRB-HICOM Bhd – Company Profile
DRB-HICOM Bhd (DRB-HICOM), an Etika Strategi Sdn Bhd subsidiary, is a diversified enterprise involved in automotive, property and asset and construction businesses. The company manufactures, assembles, distributes and markets motorcycles, military vehicles, motorcycle assembly, utility vehicles, and special purpose vehicles including related spares and services. It also provides automotive maintenance and after-sales services for a wide range of vehicles, property development, asset management vehicle inspection, banking and financial services, education and training services, courier and retail service, logistics, and component...
Add to Basket -
Company Profile
![]()
Eisai Co Ltd – Company Profile
Eisai Co Ltd (Eisai) is a pharmaceutical company that discovers, develops, manufactures and markets pharmaceuticals, including prescription medicines, OTC drugs and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex, a proton pump inhibitor, Aricept, an anti-Alzheimer agent, perampanel, Halaven, an anti-cancer agent, Fycompa tablets for the treatment of epilepsy and peripheral neuropathy. Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK,...
Add to Basket -
Product Insights
![]()
Varian Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Varian Medical Systems Inc (VMS) designs, manufactures, and sells medical devices, associated hardware and software, and a broad portfolio of interventional solutions for the treatment of cancer. The company’s major product areas include radiosurgery, radiotherapy, proton therapy, brachytherapy, adaptive therapy, interventional therapy, and software. VMS markets its products to private and government institutions, university research and community hospitals, oncology practices, healthcare agencies, physicians’ offices, radiotherapy centers, and cancer care clinics in North America, Europe, Asia-Pacific, the Middle East, and Africa....
-
Product Insights
![]()
Raysearch Laboratories AB Pipeline Insight and Competitive Landscape, 2023
RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raycare, and raystation. Its services include installation, support, training and training schedule. RaySearch’s products provide automated planning, adaptive therapy solutions, proton therapy solutions, visual simulations and other solutions for oncology treatment. The company conducts research and development to ensure the long-term development of new functions and solutions for planning and treatment of oncology related...
-
Product Insights
![]()
Giner Inc Pipeline Insight and Competitive Landscape, 2023
Giner Inc (Giner) is a developer of proton exchange membranes and electrochemisty products. The company offers products such as electrolyzer stacks and systems. Its solutions include membrane characterization, dimensionally stable membrane, water quality sensors, trace gas sensors, ozone generators, advanced chemistry batteries, direct methanol fuel cells, and cell and tissue preservation. Giner’s technologies include membrane characterization, dimensionally stable membrane, water quality sensors, metal sensors, trace gas sensors, ozone generators, chemistry batteries and direct methanol fuel cells. The company also offers...
-
Sector Analysis
![]()
Low-Carbon Hydrogen Market Size, Trends, Country Analysis, Production Process, Cost by Technology, Key Players and Forecast to 2030
Accessing the in-depth insight from the ‘Low-Carbon Hydrogen Market’ report can help you: Facilitate decision-making by providing trend analysis in the low-carbon hydrogen market. Develop business strategies by understanding the drivers and challenges of the market. Position yourself to gain the maximum advantage of the industry’s growth potential. Maximize potential in the growth of the low-carbon hydrogen market Identify key partners, geographies, and business-development avenues. Analyze the key end-users, market size, growth, demand, as well as the cost of production...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (aceclofenac + esomeprazole)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (aceclofenac + esomeprazole) Drug Details Aceclofenac in combination with esomeprazole is under development for...
-
Product Insights
![]()
Net Present Value Model: Ruibote
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ruibote Drug Details Rabeprazole Sodium (Rui...
-
Product Insights
![]()
Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics, proton pump inhibitors, and bile-salt binders The Short Bowel Syndrome pipeline drugs market research report provides comprehensive information on...
-
Product Insights
![]()
Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peptic Ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target,...
-
Product Insights
![]()
Net Present Value Model: Dexilant
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Dexilant Drug Details Dexlansoprazole (Dexilant/ Dexilant...
-
Product Insights
![]()
Net Present Value Model: Takecab
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Takecab Drug Details Vonoprazan fumarate (Takecab,...
-
Product Insights
![]()
Net Present Value Model: Pariet/Aciphex
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pariet/Aciphex Drug Details Rabeprazole Sodium (Aciphex,...
-
Analyst Opinions
![]()
Hydrogen Economy – Key Disruptive Forces for Global Transition to Sustainable Energy
Hydrogen Economy Report Overview The hydrogen economy boom is backed by the global need for sustainable energy. Hydrogen is anticipated to be a game changer in the global transition to sustainable energy by offering fuel cells, alternative propulsion systems, and renewable power. The major drivers of the hydrogen economy include zero carbon emissions, declining production costs, and substitute products. Producing hydrogen from renewable energy sources enables large-scale decarbonization. Â Hydrogen fuel cells provide instantaneous power generation and resolve demand response problems...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – azeloprazole sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry azeloprazole sodium Drug Details Azeloprazole sodium (E-3710; Z-215) was under development for the treatment...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – vonoprazan fumarate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry vonoprazan fumarate Drug Details Vonoprazan fumarate (Takecab, Inzelm, Vocinti, Denziza) is a novel anti-secretory...
-
Product Insights
New![]()
Proton Delta Sunrise Project
Proton Delta Sunrise Project is a thermal project located in Delta, Nigeria. The project is owned by Proton Energy Ltd and is developed by Proton Energy Ltd; Siemens Energy AG. The project is currently under construction. Empower your strategies with our Proton Delta Sunrise Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Track & Monitor
![]()
Environment Sustainability in Oil & Gas: Aviation Bio-Fuels
Innovations in oil & gas industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in oil & gas industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they...
-
Product Insights
![]()
Mayo Clinic – Rochester Proton Beam Cancer Therapy Facility Expansion – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mayo Clinic - Rochester Proton Beam Cancer Therapy Facility Expansion - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.